ABSTRACT. Using an isolated salt-perfused lung model in rabbits from 1 to 21 d of age, we measured the concentration of epinephrine in the pulmonary venous drainage and the pulmonary vascular response after a single dose of intratracheal epinephrine (0.1 pg/g body weight). Lungs from 30 rabbits were isolated, ventilated, and perfused at one of four age groups (n = 7-8 per group). After ventilation/perfusion was judged to be stable, saline control was injected into the trachea, changes in pulmonary pressure were recorded, and perfusate was collected for 45 s. After restabiliition, epinephrine was injected into the trachea, changes in pulmonary vascular pressure were recorded, and perfusate was collected for 45 s x two aliquots. Perfusate epinephrine concentrations were determined by HPLC. Little epinephrine was detected in the perfusate after control over all age groups, and little vascular response was noted. There was a significant age-related increase in perfusate epinephrine concentration as well as an age-related increase in vascular response (increased PAP), with the maximum epinephrine concentration and change in PAP noted at 14-21 d [group 4 = (1.72 0.42) x lo4 pmol/L]. Also, in rabbits less than 6 d of age, deposition of epinephrine into the pulmonary venous drainage was delayed. In the rabbit model, the concentration of epinephrine reaching the heart via pulmonary circulation after intratracheal injection is, at birth, very low, and the pulmonary vascular response is diminished. Both increase as a function of age until 14- Epinephrine is used to stimulate the failing heart during resuscitation attempts in adults and infants. Clinically, both i.v. and intratracheal administration have been used with success (I), although to achieve adequate epinephrine levels in the blood a 10-fold higher dose is required for intratracheal compared with i.v. administration (1-3). Little is known concerning the most appropriate manner of delivery in the neonate. Administration 
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of the drug via an endotracheal tube is accepted by the Neonatal Resuscitation Program criteria sponsored by the American Heart Association and the American Academy of Pediatrics (4). The pharmacokinetics and physiologic effects of intratracheal epinephrine in neonates have not been well researched. There is evidence that in newborn mammals the adrenergic system is immature in terms of number of receptors, the ability of the receptor to bind with a ligand, and the ability to generate a measurable response (5-7), although, clinically, newborns do respond to infusions of catecholamines with changes in blood pressure and heart rate (8, 9) . With intratracheal injection, one of the factors that would influence any physiologic action on the heart is the ability of the drug to diffuse from the airway into the pulmonary venous drainage.
We hypothesized that the efficacy of intratracheal epinephrine as a resuscitation drug would be influenced, at least in part, by diffusion of the drug from the airway into pulmonary vascular space. We wanted to examine whether the amount and rate of diffusion of epinephrine from the airway into the pulmonary venous drainage changes as a function of age, related at least in part to a postnatal maturing of the lungs. Using an isolated saltperfused lung model in rabbits from 1 to 2 1 d of age, we measured and compared the concentration of epinephrine in the pulmonary venous drainage, as well as the pulmonary vascular response (change in PAP), after a single dose of epinephrine (0.1 pg/g body weight) injected intratracheally.
MATERIALS AND METHODS
The protocol was approved by the Animal Care and Use Committee at West Virginia University School of Medicine. Timed pregnant New Zealand White rabbit does were allowed to deliver spontaneously at 3 1 d gestation (full term). The pups were nested with their mothers and assigned to perfusion groups based on age: 1-3 d, 4-6 d, 7-13 d, and 14-2 1 d. On the day of perfusion, the rabbit pups were removed from the nest, taken to the laboratory, and weighed. The animals were instrumented for perfusion based on a modification of the methods described by Polak et al. (10) and Knight et al. (1 1) .
Briefly, the rabbit pups were anesthetized with 0.05 mg/g pentobarbital injected intraperitoneally. A tracheostomy was performed, and mechanical ventilation begun using a Harvard rodent ventilator (room air, rate = 20 breathslmin, tidal volume = 2 c3). The heart and lungs were exposed via a median sternotomy, heparin (100 U/100 g) was injected into the right ventricle, and a ligature was placed loosely around the pulmonic and aortic trunks. A perfusion cannula was inserted into the main pulmonary artery through a small incision in the right ventricular outflow tract. The ligature was tightened around both the pulmonary artery and aorta, and an infusion begun with Earl's i 8 balanced salt solution, with 16 mM NaHC03 added (pH 7.40). unchanged from baseline (i.e. APAP = 0). After intratracheal The tip of the left ventricle was quickly excised and a second epinephrine injection, there was a significant increase in PAP cannula was introduced into the left atrium, retrograde through consistent with vasoconstriction. In addition, we noted an agethe mitral valve, and fixed into position with a ligature around related change in the degree of PAP increase ( p = 0.08 across all both ventricles. The ductus arteriosus was identified and ligated. four age groups, p = 0.047 between groups 1 and 4, p = 0.02
The perfusate was pumped from a syringe reservoir at a between groups 2 and 4). constant flow rate [2 mL/(min .50 g body weight-')] through a
The epinephrine concentration-age group curves for Fx. 1, heat exchanger (temperature = 37°C) and into the pulmonary Fx.2, and Fx.3 are graphically represented in Figure 1 . After artery, where it circulated through the lungs and returned to the saline control (Fx. 1), very little epinephrine was found in the reservoir via the left atrial catheter. Mean PAP was continuously perfusate from age groups 1, 2, or 3. This level of presumably measured by a pressure transducer connected to a physiologic endogenous epinephrine increases slightly ( p = 0.06) by age recorder. group 4 (14-21 d) to (0.21 + 0.12) x lo4 pmol/L (38.8 5 22.8
The protocol was designed to investigate deposition of exoge-ng/mL). nous epinephrine into the pulmonary vasculature after intratraAs noted previously, perfusate was collected in two aliquots cheal injection, as a function of age. The physiologic effect of after epinephrine injection. Perfusate collected for the first 45 s intratracheal epinephrine, in terms of change in PAP, was also after intratracheal epinephrine (Fx.2) showed a significant ( p < measured. After instrumentation, the flow rate was adjusted, and 0.001) age-related increase in epinephrine from (0.16 5 0.06) X the lung preparation was allowed to stabilize in terms of PAP, lo4 pmol/L (29.1 f 10.6 ng/mL) in age group 1 to (1.72 f 0.42) perfusion temperature (37"C), and pH (7.40). After a 15-min x lo4 pmol/L (315.1 f 76.8 ng/mL) in age group 4. There was stabilization period, 0.01 mL/g physiologic saline was injected also an age-related increase in epinephrine concentration in the into the trachea as a control. Mechanical ventilation was inter-perfusate collected from 46 to 90 s after epinephrine injection rupted during the intratracheal injection, then resumed imme-(Fx.~), from (0.33 f 0.09) X lo4 pmol/L (60.4 5 The use of neonatal rabbits combined with an isolated perfused calculated as a determination of lung d e m a -From our previous lung preparation has proved to be an effective method of studying experience, the wet/dry weight ratio ranges from 4 to 8 under pulmonary pharmacodynamics (10, 14) . The isolated perfused conditions where edema development is minimal (10, 12) . Con-lung has also proved to be suitable for the study of organ-specific centration of epinephrine from all perfusate samples was deter-responses to pharmacologic manipulation (j.e. adrenergic stimmined by HPLC with a Waters P Bonda~ak c18 3.9 x 300 mm ulation) (10, 15) . Normal cytoarchitecture, cell to cell interacanalytical column (Waters Co., Milford, MA) and electrochem-tions, and the relationships between the airways, alveoli, and ical detection. With this equipment, epinephrine and metabolites pulmonary vasculature are preserved. With the environment, can be measured to the pg/mL range (1 3).
perfusate composition, flow, ventilation, temperature, and pH Regression curves were constructed for the mean concentra-kept constant in all experiments, the sole variables are related to tion of epinephrine in the perfusate versus rabbit age group ( n = animal age (increase in size and maturity). Using this simple 7-8 Per age group). Cbrves were generated for: 1 ) Fx.1, saline model, we have shown that during the first several days of life control; 2) Fx.2,0-45 s after epinephrine injection; 3) Fx.3,46-the concentration of epinephrine found in the pulmonary venous 90 s after epinephrine injection. The perfusate ~~n~e n t r a t i~n drainage immediately after an intratracheal injection of epinephversus age g o u p curves were analyzed by regression analysis. rine is quite low, but increases as a function of age for the first comparison^ of perfusate epinephrine concentration^ VeCUs age 2-3 wk of life. It is also apparent that during the first week of groups were made using sinde-factor ANOVA. Comparisons of life there seems to be a delay in diffusion of the epinephrine into epinephrine concentrations from Fx-1, Fx.2, and Fx.3, within the pulmonary vasculature. A physiologic effect of intratracheal each age group were made by single-factor ANOVA for repeated epinephrine on the pulmonary vasculature (increase in PAP) is measures.
noted in all age groups, and also shows a significant age-related Mean values for APAP after saline control and epinephrine change. from each age group were compared within each age group by
The amount of epinephrine that reaches the pulmonary vassingle-factor ANOVA for repeated measures and across age culature, as well as the rate of drug diffusion, is influenced by groups by single-factor ANOVA.
several factors that may account for these differences. These All data are presented as means f SEM.
variables are the lung surface area over which the drug may be deposited and the bamers, or lack thereof, to diffusion of the RESULTS drug into the vasculature. In the neonatal animal, the lungs can maintain extrauterine life but cannot be considered to be mature A total of 30 separate experiments were performed, one each (1 6-18) . Respiration takes place primarily in respiratory bronchi for 30 rabbits of various ages. Rabbit age groups, weight, perfus-and a few terminal alveoli. The respiratory surface area:dead ate flow rate, wetidry lung weight ratio, and baseline PAP as space surface area ratio is quite low. In addition, the epithelial well as the changes in PAP in response to saline control and linings of respiratory bronchi and alveoli are thickened compared epinephrine injection are detailed in Table 1 . The change in PAP with those of adult lungs, causing an additional bamer to drug after saline injection was similar in all age groups and essentially diffusion (19) . On the vascular side, the pulmonary vascular 460 MULLETT ET AL. t At all age groups, saline APAP is not different from baseline (APAP = 0) and Epi APAP is significantly different (p < 0.05) from saline APAP by ANOVA for repeated measures. $ Significant ( p 5 0.05) difference between groups 1 and 4 and between groups 2 and 4 as determined by single-factor ANOVA.
the drug. One may assume that in the older animals a greater fraction of the drug deposits on the more absorptive areas of the lungs.
In the young rabbits, less than 1 wk old, we also noted a significant delay in diffusion of epinephrine into the pulmonary venous drainage. This delay is also consistent with the notion that the smaller caliber of the conducting airways of these young animals inhibits penetration of the drug to the respiratory bronchioles and alveoli and that the immature lining cells may present a bamer to drug diffusion into the vascular space.
Another factor that could alter the amount of epinephrine reaching the perfusate would be metabolism of the injected epinephrine within the lung. If epinephrine metabolism was a factor, metabolites should have been detected by the HPLC (1 3).
Age group
We noted no evidence of epinephrine metabolites in the HPLC walls of the newborn are thick, also presenting a diffusion barrier. The wall thickness of arterioles decreases over the first 10 d to 2 wk of life, primarily due to vasodilation (20) . Lung growth in terms of both increased surface area and maturation of endobronchial and alveolar lining cells, as well as the maturation of the pulmonary vasculature, continues well after birth (17) (18) (19) (20) . It is likely that postnatal maturational changes in these two factors, site of drug deposition and barriers to drug diffusion, account for the age-related perfusate epinephrine concentration changes noted in our study. From experience with intratracheal injection of liquids (i.e. exogenous surfactant), it is apparent that a bolus of liquid will deposit into the deep airways and alveoli with mechanical ventilation (21) . The ventilatory pressure required to deliver the liquid to the respiratory bronchi and alveoli is governed somewhat by Poiseuille's law of fluid flow through a tube, which states that resistance to flow is inversely proportional to the radius of the tube, such as the bronchi and terminal bronchi (22) . Thus, at birth, with a given tidal volume and ventilatory pressure, a larger proportion of the injected epinephrine is likely to be deposited in the conducting airways compared with the older animal, where the increased radii of the rapidly growing bronchial tree is likely to permit further penetration of data and as such do not believe that this can account for the alterations noted.
We also noted a significant change in the pulmonary vascular response to injected epinephrine. Several factors may be responsible for this. The depressed physiologic response may be another indication of the barriers to diffusion of the drug from the airway into the vascular space. However, these changes are also consistent with studies that have demonstrated that the adrenergic system in newborn mammals is immature in terms of number of receptors, the ability of the receptor to bind with a ligand, and the ability to generate a measurable response (5-7). The adrenergic receptors and related mechanisms mature within the first several weeks of life. This factor may further influence the cardiovascular responses, or lack thereof, of intratracheal epinephrine in the neonate.
In summary, we have shown that there is an age-related change in the rate of diffusion as well as the absolute amount of epinephrine that reaches the pulmonary venous drainage after a single intratracheal epinephrine injection. Furthermore, the physiologic response to epinephrine, at least in the pulmonary vasculature, changes with age. These changes are likely to be related to the rapidly changing architecture of the neonatal lung and continuing postnatal development of the adrenergic system. Although the isolated perfused lung is a simplified model, our results may have relevance in resuscitation attempts in human neonates. One must also consider a host of other factors, including acidosis, hypoxemia, and low flow states, that may further alter the diffusion and physiologic action of epinephrine.
